BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fletcher J, Alhusayen R, Alavi A. Recent advances in managing and understanding pyoderma gangrenosum. F1000Res 2019;8:F1000 Faculty Rev-2092. [PMID: 31885859 DOI: 10.12688/f1000research.19909.1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Leow LJ, Zubrzycki N. Recalcitrant Ulcerative Pyoderma Gangrenosum of the Leg Responsive to Tildrakizumab: A Case Report. Clin Cosmet Investig Dermatol 2022;15:1729-36. [PMID: 36039180 DOI: 10.2147/CCID.S374534] [Reference Citation Analysis]
2 Bazzi N, Salloum A, Chebl JA, Hreibe W, Bazzi M, Fiani E, Benedetto A, Moussa M. Juvenile gangrenous vasculitis of the scrotum: systematic review. Int J Dermatol 2022. [PMID: 35323998 DOI: 10.1111/ijd.16066] [Reference Citation Analysis]
3 Costescu Strachinaru DI, De Greef A, Marot L, Lerate V, Paridaens M. Pyoderma gangrenosum induced by transcutaneous electrical nerve stimulation: a case report with literature review. Oxford Medical Case Reports 2022;2022:omac017. [DOI: 10.1093/omcr/omac017] [Reference Citation Analysis]
4 Rasul TF, Mathew M, Anderson JD, Bergholz DR, Henderson A. Resource-Limited Management of Presumptive Pyoderma Gangrenosum in an Unsheltered Patient. Cureus. [DOI: 10.7759/cureus.21629] [Reference Citation Analysis]
5 Wallace CE, Sharma A. Pyoderma Gangrenosum in an African American Male Initially Presenting as Sepsis. Cureus. [DOI: 10.7759/cureus.21592] [Reference Citation Analysis]
6 Burlando M, Paravisi A, Bodini G, Cozzani E, Parodi A. Crushed Corticosteroid Tablets in Peristomal Pyoderma Gangrenosum: A Case Report. J Wound Ostomy Continence Nurs 2021;48:460-2. [PMID: 34495940 DOI: 10.1097/WON.0000000000000798] [Reference Citation Analysis]
7 Opalińska A, Kwiatkowska D, Burdacki A, Markiewicz M, Samotij D, Dudziński M, Niemiec-Dudek J, Ostańska E, Reich A. Multifocal Pyoderma Gangrenosum with an Underlying Hemophagocytic Lymphohistiocytosis: Case Report and the Review of the Literature. Dermatol Ther (Heidelb) 2021;11:1217-37. [PMID: 34176093 DOI: 10.1007/s13555-021-00571-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Baier C, Barak O. Guselkumab as a treatment option for recalcitrant pyoderma gangrenosum. JAAD Case Rep 2021;8:43-6. [PMID: 33490346 DOI: 10.1016/j.jdcr.2020.12.005] [Reference Citation Analysis]
9 Ronchetti S, Ayroldi E, Ricci E, Gentili M, Migliorati G, Riccardi C. A Glance at the Use of Glucocorticoids in Rare Inflammatory and Autoimmune Diseases: Still an Indispensable Pharmacological Tool? Front Immunol 2020;11:613435. [PMID: 33584696 DOI: 10.3389/fimmu.2020.613435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kus KJB, Ruiz ES. Wound Dressings – A Practical Review. Curr Derm Rep 2020;9:298-308. [DOI: 10.1007/s13671-020-00319-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
11 Greydanus DE, Azmeh R, Cabral MD, Dickson CA, Patel DR. Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life. Dis Mon 2021;67:101103. [PMID: 33041056 DOI: 10.1016/j.disamonth.2020.101103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Maverakis E, Marzano AV, Le ST, Callen JP, Brüggen M, Guenova E, Dissemond J, Shinkai K, Langan SM. Pyoderma gangrenosum. Nat Rev Dis Primers 2020;6. [DOI: 10.1038/s41572-020-0213-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
13 Schlott S, Karrer S, Terhorst-Molawi D, Dissemond J. Pyoderma gangrenosum as a late complication in tattoos: A case report series. Int Wound J 2020;17:2031-2. [PMID: 32662569 DOI: 10.1111/iwj.13453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]